Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Alesiani

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Chemical Physics|December 18, 2023
Self-tuning Hamiltonian Monte Carlo for accelerated samplingHenrik Christiansen, Federico Errica, Francesco Alesiani
Journal of Chemical Theory and Computation|February 5, 2026
Performance of Universal Machine-Learned Potentials with Explicit Long-Range Interactions in Biomolecular SimulationsViktor Zaverkin, Matheus Ferraz, Francesco Alesiani, et al.
The Journal of Chemical Physics|November 11, 2025
Fast, modular, and differentiable framework for machine learning-enhanced molecular simulationsHenrik Christiansen, Takashi Maruyama, Federico Errica, et al.
Leukemia & Lymphoma|November 12, 2010
The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxisAlessandro Isidori, Francesco Merli, Francesco Angrilli, et al.
International Journal of Cancer|December 3, 2013
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2Maria Beatrice Morelli, Massimo Offidani, Francesco Alesiani, et al.
Leukemia & Lymphoma|June 24, 2008
R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot studyGiuseppe Visani, Felicetto Ferrara, Francesco Alesiani, et al.
Leukemia & Lymphoma|February 17, 2012
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myelomaMassimo Offidani, Claudia Polloni, Federica Cavallo, et al.
The Oncologist|April 26, 2012
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGAAttilio Olivieri, Guido Gini, Caterina Bocci, et al.
European Journal of Haematology|April 9, 2013
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemiaAlessia Dalsass, Francesca Mestichelli, Miriana Ruggieri, et al.
European Journal of Haematology|May 18, 2013
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromesAntonella Poloni, Gaia Goteri, Antonio Zizzi, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Chemical Physics|December 18, 2023
Self-tuning Hamiltonian Monte Carlo for accelerated samplingHenrik Christiansen, Federico Errica, Francesco Alesiani
Journal of Chemical Theory and Computation|February 5, 2026
Performance of Universal Machine-Learned Potentials with Explicit Long-Range Interactions in Biomolecular SimulationsViktor Zaverkin, Matheus Ferraz, Francesco Alesiani, et al.
The Journal of Chemical Physics|November 11, 2025
Fast, modular, and differentiable framework for machine learning-enhanced molecular simulationsHenrik Christiansen, Takashi Maruyama, Federico Errica, et al.
Leukemia & Lymphoma|November 12, 2010
The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxisAlessandro Isidori, Francesco Merli, Francesco Angrilli, et al.
International Journal of Cancer|December 3, 2013
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2Maria Beatrice Morelli, Massimo Offidani, Francesco Alesiani, et al.
Leukemia & Lymphoma|June 24, 2008
R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot studyGiuseppe Visani, Felicetto Ferrara, Francesco Alesiani, et al.
Leukemia & Lymphoma|February 17, 2012
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myelomaMassimo Offidani, Claudia Polloni, Federica Cavallo, et al.
The Oncologist|April 26, 2012
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGAAttilio Olivieri, Guido Gini, Caterina Bocci, et al.
European Journal of Haematology|April 9, 2013
6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemiaAlessia Dalsass, Francesca Mestichelli, Miriana Ruggieri, et al.
European Journal of Haematology|May 18, 2013
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromesAntonella Poloni, Gaia Goteri, Antonio Zizzi, et al.
Pageof 3